Platinum-based chemotherapy (cisplatin or carboplatin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Platinum-based chemotherapy (cisplatin or carboplatin), covering 2025-12-03 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) [Phase 2]